Etiology Grants

The Education Scientific Assembly (ESA) of the American Society for Clinical Laboratory Science announces the competition for CLS/CLT student research papers and case studies. Student Research Papers should address scientific as well as applicable educational, technical, administrative, consulting, and management studies. Case Studies should address any unusual, interesting, and unique manifestation of a disease etiology, pathology, clinical syndrome, complications and prognosis known or unknown.

Eligibility

Research Paper: Student must be a current ASCLS member and have been enrolled in a NAACLS accredited CLS/CLT program at the time the research was conducted.

Case Studies: Student must be a current ASCLS member and presently enrolled in a NAACLS accredited CLS/CLT program. Case Studies should be from actual patient cases and address any unusual, interesting, and unique manifestation of a disease etiology, pathology, clinical syndrome, complications and prognosis known or unknown.

Awards

Research paper: Travel expenses to the ASCLS national meeting. Paid expenses include airfare, registration, and single room for the duration of the meeting

Case Study: $500 cash award.

Conditions

The student winning the research paper award will present their paper during the ASCLS national meeting. The student awards will be presented at the awards ceremony during the ASCLS national meeting.

Students can also submit their papers/cases to the journal Clinical Laboratory Science to be reviewed for publication.

Research papers/cases will be judged according to guidelines in Instructions to Authors for the journal Clinical Laboratory Science. Failure to follow guidelines will result in rejection from judging.

Review of the paper/case will be anonymous. Designated representatives of the ESA will review papers/cases. Reviewers are expected to disqualify themselves if a paper/case is from their institution or there is a conflict of interest. Reviewers should abstain from grading if the subject is outside the reviewer(s) area of expertise. Authors will be notified by mail of awards soon after the review process. Date and time of research paper presentation will be included in the notification letter.

Papers/cases that are not dated by the deadline will be rejected without review and the submitter(s) will be notified.
By May 1:

* Fax one signed copy of the application cover sheet to Joan Polancic, ASCLS Director Education at 303-904-8933. Click here to print a MS-Word file of the cover sheet.
* Email one copy of the research paper or case study (Word or Word Perfect format) to joanp@ascls.org. Include the research paper or case study title, author name, and institution address on the paper's coversheet.

Deadline
May 1

Send to:
Joan Polancic
ASCLS Director of Education
fax: 303-904-8933
joanp@ascls.org

Criteria for Judging Research Papers

Research papers will be judged according to guidelines in Instructions to Authors. Click here to print a MS-Word copy of Instructions to Authors.
Basis of Grading Scale:

1. Overall assessment of the investigation’s applicability and inherent value to CLS practitioners.
2. The validity of the author’s conclusion in reference to the hypothesis of problems, statistical findings, and their level of significance.
3. Organization of the paper.
4. Adherence to format in published instructions

Criteria for Grading a Case Study
Case studies will be judged according to guidelines in "Instructions to Authors."

Scientific Merit

* Case demonstrates extensive study of the subject (population), a valuable contribution to Clinical Laboratory Science/Clinical Laboratory Technology profession, allied health education, health care, and medicine.
* Case represents uncommon disease condition, outcome of disease, unusual complications, education or management outcome and/or methodology.
* Case study is clearly and thoughtfully organized, ideas well defined and comprehensive.
* Interpretation of the case is presented sufficiently with implications for its relevance for clinical application or valuable contribution to the clinical laboratory science practice and profession.

Format and Presentation

* Writing shows good clarity, broad and precise vocabulary attuned to the scientific discipline and correct grammatical usage.
* Patient history and disease condition and/or new innovative practice are described.
* Main outcome measurements reflect the impact of achieving patient outcomes stated with adequate clarity.
* All aspects of instructions to authors are followed.

Preparation of Copy

All case studies/research papers must be double-spaced and typed with margins of 1 inch on all edges. Cover page must be included; no abstract is required for initial submission. Recommended typeface is Times New Roman, 12-point type. Text format is flush left. To encourage consistency in style refer to guidelines in "Instructions to Authors."

Doris Duke Clinical Scientist Development Award

The purpose of the Doris Duke Clinical Scientist Development Award Program is to provide support for
mentored research to junior faculty members with an M.D. or M.D./Ph.D. (physician-scientists) working
in any disease area as they begin their careers as independent clinical researchers.

The early stage of career development, when a researcher is transitioning from working in a mentor’s
laboratory to setting up an independent research program and obtaining grant funding, is a critical
period. It is often more difficult for physician-scientists who are conducting clinical research to make
this transition than it is for other researchers because these individuals typically have to balance the
demands of seeing patients with those of conducting research. Those demands, together with the
complexity of today’s research environment and the pace of progress, make it particularly challenging to
maintain the knowledge base needed to be both a clinician and a researcher. Nevertheless, the role of the
physician-scientist in providing the bridge between the clinic and the laboratory is critical for the timely
translation of basic research findings into therapeutic approaches and for the transfer of clinical
knowledge back to the laboratory.

The 2009 Clinical Scientist Development Awards are being offered to eligible junior faculty members at
a funding level of $135,000 per year for 3 years. It is DDCF’s hope that by providing stable support at a
critical career juncture for physician-scientists, the Clinical Scientist Development Award will
encourage physicians to pursue careers in clinical research.

Definition of Clinical Research
For the purposes of this award program, clinical research is defined as research conducted with human
subjects with direct application to the prevention, diagnosis, treatment, or cure of any human disease.

The Foundation’s definition of clinical research includes:
• Studies on the etiology and pathogenesis of human disease
• Therapeutic interventions
• Clinical trials
• Epidemiological studies
• Disease control research
• Operations and implementation research

Eligibility of Nominee
This program is specifically intended to help physician-scientists make the critical transition from
training to independence as clinical investigators.
It is the responsibility of each institution to ensure that its nominees meet all of the eligibility
requirements. The replacement of nominees will not be permitted.
Applicants must:
• Be a physician-scientist conducting clinical research in any disease area;
• Have received an M.D. or a foreign equivalent from an accredited institution;
• Be working in a U.S. degree-granting institution, but do not have to be a U.S. citizen;
• Have a full-time faculty level position not higher than the Assistant Professor level; and
• Have been appointed to their first full-time faculty level position between January 1, 2004 and
January 1, 2009. (All full-time post-fellowship Instructor level positions will be considered full-time
faculty level appointments).

Online Submission of Nominations
Institutions nominating candidates must submit their nominations using the online system at
http://www.ddcf.org/apps/csda/index.asp on or before 5 pm EST on November 5, 2008. Before entering
the online system, please be sure that you gather all the required information listed in the instructions for
nomination which are available at http://www.ddcf.org/mrp-csda. All of an institution’s nominations
must be entered at the same time. Nominations submitted by other methods will not be accepted. It is the
responsibility of the institutions to ensure that candidates nominated

Request For Applications: Incentive Grants for New Investigators in Gambling Research

APPLICATION DEADLINE: NOVEMBER 3, 2008
The Institute for Research on Pathological Gambling and Related
Disorders is pleased to announce the availability of Incentive
Grants of up to $25,000 per year for two years. The purpose of this
award is to encourage new investigators to enter the field of gambling
studies by providing seed funds for research on gambling and gamblingrelated
problems. Investigators who have a terminal degree (e.g., Ph.D.,
M.D., M.P.H., J.D.) and who have no more than 10 years of post-graduate
research training experience at the time of the application receipt date
(November 3, 2008) are eligible to apply for an Incentive Grant.

ELIGIBLE APPLICANTS
To be eligible for an Incentive Grant,
applicants must have a terminal degree
(e.g., Ph.D., M.D., M.P.H., J.D.) and no
more than ten years of post-graduate
research training experience at the time of
the application receipt date (November 3,
2008). This grant category is intended to
support new investigators (e.g., postdoctoral
fellows, assistant professors, or
equivalent). Students and investigators
with rank higher than assistant professor
are not eligible to apply.
Applicants are eligible for a maximum of
two Incentive Grants for New Investigators.
Previous awardees at the post-doctoral or
assistant professor level are encouraged to
apply for a second award. However, awards
cannot overlap in time. Applicants must
not submit more than one application per
cycle.
PRIORITY AREAS
The Institute requests proposals for
investigator-initiated research that will
consider the influence of cognitive,
personality, emotional, neurobiological,
economic, and psychosocial influences
associated with the etiology, maintenance
of and recovery from gambling disorders.
While a broad range of topics will receive
consideration, the Institute is especially
interested in the following areas:
• Treatment outcome
• Self-guided recovery and brief
interventions
• Determinants of disordered
gambling
• Resilient and vulnerable population
segments
• Comorbidity
• Prevention and responsible gaming
• Neurobiology of gambling disorders
• Social and economic impact

The Division on Addictions
Cambridge Health Alliance
an affiliate of Harvard Medical School
Station Landing
101 Station Landing, 2nd Floor
Medford, MA 02155
Phone: (781) 306-8600

Email: info@divisiononaddictions.org

Expertise Transfer Fellowship

The IARC is offering an Expertise Transfer Fellowship to enable an established investigator to spend normally from six to twelve months in an appropriate host institute in a low- / medium-resource country* in order to transfer knowledge and expertise in a research area relevant for the host country and related to the Agency's programmes: epidemiology, biostatistics, environmental chemical carcinogenesis, cancer etiology and prevention, infection and cancer, molecular cell biology, molecular genetics, molecular pathology and mechanisms of carcinogenesis.

Applications should include a proposed collaborative research project, specifying the link to IARC's on-going activities and a letter of support from the host lab giving details of feasibility and anticipated benefit to the receiving institute. A letter of endorsement from a research Group at IARC must also be provided. Priority will be given to projects directly linked to IARC's on-going research programme, involving at least one contact at IARC.

Applicants should be established cancer researchers actively engaged in the field with appropriate scientific or medical qualifications and an excellent publications' record. They must also belong to the staff of a university or a research institution.
Deadline for receipt of applications is: 30 November 2008

Candidates will be notified of the outcome of their application by the end of April 2009. There will be an annual remuneration of up to US$70,000, which will take into account the on-going salary of the Fellow. This amount may include limited support for the project. The cost of travel will also be met. The Award should be taken up no later than November 2009.

(*any country other than those classified as high-income economies by the World Bank)

Fellowship application forms and more detailed information are available from:

Fellowship Programme
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER
150 cours Albert-Thomas, 69372 Lyon Cedex 08, France
Tel: +33 (0)472 73 84 48; Fax: +33 (0)472 73 80 80; E-mail: fel@iarc.fr

Visiting Scientist Award

The IARC is offering a Visiting Scientist Award for a qualified and experienced investigator with recent publications in international peer-reviewed scientific journals who wishes to spend from six to twelve months at the IARC working on a collaborative project in a research area related to the Agency's programmes: epidemiology, biostatistics, environmental chemical carcinogenesis, cancer etiology and prevention, infection and cancer, molecular cell biology, molecular genetics, molecular pathology and mechanisms of carcinogenesis.

Candidates are requested to contact the relevant Scientific Groups in order to set up a collaborative project. For details on scientific programmes and research groups please consult the IARC Web site: http://www.iarc.fr/en/Research-Groups/Clusters-Groups, or contact the IARC at the address below.

Applicants must belong to the staff of a university or a research institution and should provide written assurance of a post to return to at the end of the period of award.
Deadline for receipt of applications is: 30 November 2008

Candidates will be notified of the outcome of their application by the end of April 2009. There will be an annual remuneration of up to US$80,000-, which will take into account the on-going salary of the visiting scientist plus the cost of travel. The Award should be taken up no later than 30 November 2009.

Fellowship application forms and more detailed information are available from:

Fellowship Programme
INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC)
150 cours Albert-Thomas, 69008 Lyon, France
Tel: +33 (0)472 73 84 48; Fax: +33 (0)472 73 80 80; E-mail: vsa@iarc.fr

Potamkin Prize for Research in Pick's, Alzheimer's, and Related Diseases
Sponsored by the American Academy of Neurology and the AAN Foundation and funded through the philanthropy of the Potamkin Foundation.

This award recognizes major contributions to the understanding of the causes, prevention, treatment, and cure for Pick's, Alzheimer's, and related diseases.

Presentation
Recipient is expected to present a 20-minute lecture during an aging and dementia scientific session at the 61st AAN Annual Meeting.

Recipient will receive:

Medallion and $100,000 prize
Complimentary registration for 61st Annual Meeting
Recognition at 2009 Awards Luncheon at 61st Annual Meeting
Eligibility
Must be in any of the following biological disciplines: neurology, neuropathology, biochemistry, molecular biology, molecular genetics, chemistry, pharmacology, immunology, physiology, or cell biology

Application Procedure

Applicants should submit one complete set of the following materials:

Completed application form
Current curriculum vitae
Letter citing scientific accomplishments in detail
Two recommendation letters
Up to six selected reprints

Deadline

The deadline to apply for 2009 AAN Scientific Awards is November 3, 2008. Applications will be available in August 2008.

For more information, please contact Erin Jackson at ejackson@aan.com or (651) 695-2704.

The Eli and Edythe Broad Foundation created the Broad Medical Research Program (BMRP) for Inflammatory Bowel Disease (IBD) Grants in 2001.

IBD refers to two chronic inflammatory gastrointestinal disorders: Crohn's disease and ulcerative colitis. Although numerous scientific advances have been made in understanding and treating IBD, the precise cause, successful treatment and prevention of IBD remain unknown.

The Eli and Edythe Broad Foundation, through the BMRP, provides 40 percent of all private funding for IBD research in the United States. Our approach is different than many traditional scientific and medical funding organizations. We fund early stage investigation – with the goal that innovative ideas need financial support for early testing to ultimately lead to effective treatment, diagnosis and prevention of IBD.

The BMRP provides rapid funding to investigators working in non-profit organizations worldwide for up to two years for basic or clinical IBD research projects that:

* Are innovative
* Are in the early stages of exploration
* Will improve the diagnosis, therapy or prevention of IBD in the near future; and
* Will lead to longer-term funding by more traditional granting agencies

The BMRP provides funding to generate pilot research data, rather than serving as the final grant source for a research project. Grantees are encouraged to generate sufficient preliminary data in the first year in order to compete successfully for continuation funding from us and/or other sources.

A grantee may receive second-year funding from the BMRP if the researcher demonstrates maximal progress in the first year of the grant, validates the original research premise and demonstrates a clear need for additional preliminary data.

Because we believe that great ideas could come from non-traditional sources, we encourage basic and clinical investigators and scientists not currently working in IBD and interdisciplinary teams to apply.

There is a two-step process for requesting funding from the Broad Medical Research Program (BMRP) for Inflammatory Bowel Disease:

1. The first step is to submit a Letter of Interest. Instructions and format for Letters of Interest may be found under “How to Apply.” Decisions on Letters of Interest are based on external expert review of the proposal and usually are made within four to six weeks.

2. If the BMRP is interested in pursuing a project, an invitation is extended to submit a full grant application. At that time, the grant application instructions and forms are sent to the Principal Investigator. Decisions on grant applications are made based on external review by subject experts and usually take eight to 10 weeks.

There are no deadlines or specific dates for applications. Proposals are accepted and reviewed year-round. Revised proposals may only be submitted at the request of the BMRP.

Special Requests for Proposals

The BMRP is currently soliciting proposals in two areas of research:

Differences in IBD incidence between developing and developed countries

The BMRP is funding innovative research into the possible reasons for low and high incidence of IBD in different areas of the globe. Proposals should be exploratory in nature or designed as pilot. The research should shed light on factors that may influence low versus high global areas of prevalence of the disease. The research should ultimately be helpful in improved understanding of the etiology of IBD and the factors that enhance or prevent the genesis of the disease.

IBD and Diabetes Mellitus

The BMRP is interested in early stage exploratory innovative research proposals to investigate the similarities and differences between inflammatory bowel diseases (IBD) and diabetes mellitus (DM).

Proposals should be exploratory in nature designed as pilot projects researching possible commonality in the etiopathogenesis between IBD and DM. Human or animal model studies are welcomed.

How to Apply

Applicants should submit a brief Letter of Interest (up to three pages, not including attachments) as the initial request for funding. Investigators whose Letters of Interest fit the BMRP's criteria and areas of interest will be invited to submit a full grant application.

We recommend you review “Policies” and “Frequently Asked Questions” prior to preparing a Letter of Interest.

Letter of Interest Format

The following information is part of the three-page limit:

* Title of the project
* Specific hypothesis or question to be investigated
* Methodology
* Data analysis
* Anticipated outcomes

The following items (except for #1) are required but not part of the three-page limit:

1. Supportive information, such as references, preliminary data or recent publications, may be included.
2. State why your project fits the BMRP's criteria (see "BMRP Goals"), including its relevance and likely benefits to patients with IBD in the next several years.
3. Attach the investigator’s curriculum vitae(s) or biographical sketch(es).
4. Briefly describe the laboratory or clinical environment.
5. Indicate the estimated total budget (see “Budget” under “Policies”) and the period for which funding is requested. Keep in mind that we are interested in funding exploratory projects in order to test new ideas and directions in IBD research. Thus, funding requests should be in concert with the foundation’s purpose.
6. Provide the principal investigator’s e-mail and postal addresses.

Letter of Interest Submission

1. Direct Letters of Interest to:
Daniel Hollander, M.D.
Director
Broad Medical Research Program
The Eli and Edythe Broad Foundation, Scientific | Medical Research
10900 Wilshire Boulevard, Twelfth Floor
Los Angeles, California 90024-6532
U.S.A.
2. If possible, please send your Letter of Interest and all attachments electronically to: info@broadmedical.org. If you send it electronically, please do not send a printed copy.
3. Receipt of your Letter of Interest will be acknowledged by e-mail within a few days. If you do not hear from us in a timely manner, please contact us at info@broadmedical.org to make sure that your letter has been received.
4. You may include suggestions for potential reviewers and also indicate individuals with potential conflicts of interest.
Unless required by your institution, Letters of Interest may be submitted directly to the BMRP by the Principal Investigator and do not require institutional approval or signature.
5. Letters of Interest are accepted and reviewed throughout the year; there are no deadlines.

Cleft Palate Foundation Research Grants

The Cleft Palate Foundation (CPF) currently offers four research grants, offered each year, in the area of cleft lip, cleft palate, and related craniofacial anomalies.

Application Deadline: In order to be considered, applications must be postmarked on or before January 15 (if January 15 is a US Federal Holiday, the deadline becomes January 16).

The following is a listing and description of the four grants:

* The Cleft Lip/Palate and Craniofacial Anomalies Grant is sponsored by the American Association of Oral and Maxillofacial Surgeons in Rosemont, Illinois. The purpose of the grant is to encourage scientific research to evaluate developmental and therapeutic issues relating to cleft lip and palate and other craniofacial anomalies. This grant is available to junior and senior investigators in an amount of $10,000.
* The Etiology of Cleft Lip/Palate and Craniofacial Anomalies Research Grant is sponsored by the Peer Foundation in Florham Park, New Jersey. The purpose of the grant is to encourage scientific research on problems related to the etiology, diagnosis, and treatment of cleft lip/palate and craniofacial anomalies. It is available to junior and senior investigators in an amount of $10,000.
* The Junior Investigators Research Grant is sponsored by the Cleft Palate Foundation. The purpose of the grant is to (a) aid in the development of scientific investigators who are committed to problems related to the cleft lip and palate, and other craniofacial abnormalities, and (b) encourage scientific research on problems related to the diagnosis and treatment of cleft lip and palate, and other craniofacial abnormalities. It is offered to new investigators (those enrolled in accredited graduate training programs related to the disciplines recognized by the American Cleft Palate-Craniofacial Association; those holding the academic rank of assistant professor or below; or investigators who are no more than 5 years past their PhD or specialty professional training) and has a maximum allocation of $5,000 per year.

* The CCA Research Grant is sponsored by the Children’s Craniofacial Association of Dallas, TX. The purpose of this grant is to promote scientific research about developmental and therapeutic issues related to cleft and craniofacial conditions. It is available to junior and senior investigators with a maximum allocation of $10,000 per year.
Cleft Palate Foundation

1504 East Franklin Street, Suite 102
Chapel Hill, NC 27514-2820 USA
(919) 933-9044 , Fax: (919) 933-9604
info@cleftline.org

Targeted Research Initiative for Mood Disorders
Application Deadline: March 2, 2009
Award Amount: up to $100,000 for one year
Program information and instructions available Fall 2008
The Targeted Research Initiative for Mood Disorders supports research leading to new insights into the diagnosis etiology, complications and treatment of persons with epilepsy and mood disorders. Both clinical and basic projects are of interest, using a variety of disciplinary approaches. Investigators must hold a relevant advanced degree (M.D. and/or Ph.D.) and have completed all research training. Open to investigators based at corporations as well as academic/university settings.

Applicants may request up to $100,000 for one year. Grants awarded for higher than $50,000 per year are based on funds available and may be offered if the applicant proposes particularly meritorious work and has provided clear justification based on need and timetable of the work proposed.

Epilepsy Foundation of America® 8301 Professional Place Landover MD 20785 (800) 332 1000

Call for Grant Proposals

American Urogynecologic Society Foundation
2008 Grant Cycle Announcement and Guidelines

The AUGS Foundation is pleased to announce a request for grant proposals. Of note, the AUGS Foundation expects additional funding for grants and will announce those grants and criteria when the funds become available.

The AUGS Foundation seeks to identify future academic leaders and to stimulate their development through the support of research grants. The awards are intended to encourage and reward clinicians and scientists investigating the causes, prevention, cure, and treatment of urogynecologic disorders and pelvic floor dysfunction.

These two awards are to be used to provide research support for a fellow who exhibits significant evidence of talent and dedication to research. In general, it is expected that work supported by these funds will lead the applicant to obtain additional funding. As a result, successful applications are usually well focused, feasible and present a clear pathway from the fellow's present state to the acquisition of future funding.

Amount of Each Award

$25,000 (direct costs, US dollars)
No indirect costs to the institution and funds cannot be used for direct salary support of the fellow

Important Dates

Grant Application Opens: July 2008
Deadline for Receipt of Application: October 15, 2008 11:59 EST
Duration of Awards: 2 years
Award Notification: December 15, 2008
First Installment Funding Date: December 31, 2008

Award Programs

It is expected the awardee will present a progress report at the next AUGS Foundation Luncheon and their final results at an AUGS Annual Scientific Meeting within 1-2 years of the completion of the award.

AUGS Foundation Research Grant: This grant will be awarded to a fellow with a clinical patient-oriented research project.

June Allyson Foundation Research Fellowship Award: This grant will be awarded to a fellow with a laboratory-based research project.

Contact Us

AUGS
2025 M Street NW
Suite 800
Washington, DC 20036
Phone: (202) 367-1167
Fax: (202) 367.2167
Email: info@augs.org